- Home
- ARVN vs UNTY Comparison
ARVN vs UNTY Comparison
Compare ARVN & UNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- UNTY
- Stock Information
- Founded
- ARVN 2015
- UNTY 1991
- Country
- ARVN United States
- UNTY United States
- Employees
- ARVN N/A
- UNTY N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- UNTY Major Banks
- Sector
- ARVN Health Care
- UNTY Finance
- Exchange
- ARVN Nasdaq
- UNTY Nasdaq
- Market Cap
- ARVN 456.2M
- UNTY 458.0M
- IPO Year
- ARVN 2018
- UNTY 1997
- Fundamental
- Price
- ARVN $7.81
- UNTY $52.26
- Analyst Decision
- ARVN Buy
- UNTY Buy
- Analyst Count
- ARVN 21
- UNTY 2
- Target Price
- ARVN $20.53
- UNTY $52.50
- AVG Volume (30 Days)
- ARVN 1.8M
- UNTY 93.5K
- Earning Date
- ARVN 07-29-2025
- UNTY 07-18-2025
- Dividend Yield
- ARVN N/A
- UNTY 1.07%
- EPS Growth
- ARVN N/A
- UNTY 11.85
- EPS
- ARVN N/A
- UNTY 4.26
- Revenue
- ARVN $426,900,000.00
- UNTY $106,250,000.00
- Revenue This Year
- ARVN $7.57
- UNTY $21.68
- Revenue Next Year
- ARVN N/A
- UNTY $9.98
- P/E Ratio
- ARVN N/A
- UNTY $12.27
- Revenue Growth
- ARVN 498.74
- UNTY 6.60
- 52 Week Low
- ARVN $5.90
- UNTY $30.28
- 52 Week High
- ARVN $34.11
- UNTY $54.64
- Technical
- Relative Strength Index (RSI)
- ARVN 54.65
- UNTY 57.76
- Support Level
- ARVN $7.58
- UNTY $51.77
- Resistance Level
- ARVN $8.31
- UNTY $54.64
- Average True Range (ATR)
- ARVN 0.39
- UNTY 1.91
- MACD
- ARVN 0.03
- UNTY 0.25
- Stochastic Oscillator
- ARVN 64.75
- UNTY 52.65
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About UNTY Unity Bancorp Inc.
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.